Novel IκκB kinase inhibitors for treatment of nuclear factor-κκB-related diseases

被引：59

作者：

Suzuki, Jun-ichi ^{[1
]}

Ogawa, Masahito ^{[1
]}

Muto, Susumu ^{[2
]}

Itai, Akiko ^{[2
]}

Isobe, Mitsuaki ^{[3
]}

Hirata, Yasunobu ^{[1
]}

Nagai, Ryozo ^{[4
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo 1138655, Japan

[2] Inst Med Mol Design Inc, Tokyo, Japan

[3] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan

[4] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2011年 / 20卷 / 03期

关键词：

chemical compounds; inflammation; I kappa B kinase; NF-kappa B; HIGHLY SELECTIVE INHIBITOR; COLLAGEN-INDUCED ARTHRITIS; DECOY OLIGODEOXYNUCLEOTIDES; GENE-EXPRESSION; MYOCARDIAL-ISCHEMIA; IMATINIB-RESISTANT; THERAPEUTIC TARGET; VIVO TRANSFECTION; ATOPIC-DERMATITIS; LEUKEMIA-CELLS;

D O I：

10.1517/13543784.2011.559162

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Areas covered: NF-kappa kappa B affects the progression of inflammation-related diseases, such as myocardial ischemia, bronchial asthma, arthritis, cancer and other diseases. We review the characteristics and effects of these inhibitors on inflammatory and other diseases. Expert opinion: Various synthesized IKK inhibitors have been developed and they will be used clinically in the near future.

引用

页码：395 / 405

页数：11

共 50 条

[1] Nuclear factor-κB activation in alveolar macrophages requires Iκkinase-β, but not nuclear factor-κB inducing kinase
Conron, M
Andreakos, E
Pantelidis, P
Smith, C
Beynon, HLC
Dubois, RM
Foxwell, BMJ
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 996 - 1004
[2] Nuclear factor-κB inhibition in sepsis:: Steroids versus specific nuclear factor-κb inhibitors?
Marik, PE
CRITICAL CARE MEDICINE, 2002, 30 (10) : 2393 - 2394
[3] Inhibition of nuclear transcription factor-κB by specific IκB kinase peptide inhibitor
Swaroop, N
Chen, F
Wang, LY
Dokka, S
Toledo, D
Rojanasakul, Y
PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1631 - 1633
[4] Inhibition of Nuclear Transcription Factor-κB by Specific IκB Kinase Peptide Inhibitor
Navin Swaroop
Fei Chen
Liying Wang
Sujatha Dokka
David Toledo
Yon Rojanasakul
Pharmaceutical Research, 2001, 18 : 1631 - 1633
[5] The role of nuclear factor-κ B in pulmonary diseases
Christman, JW
Sadikot, RT
Blackwell, TS
CHEST, 2000, 117 (05) : 1482 - 1487
[6] Activation of the IκB kinase complex and nuclear factor-κB contributes to mutant Huntingtin neurotoxicity
Khoshnan, A
Ko, J
Watkin, EE
Paige, LA
Reinhart, PH
Patterson, PH
JOURNAL OF NEUROSCIENCE, 2004, 24 (37): : 7999 - 8008
[7] Herbimycin A abrogates nuclear Factor-κB activation by interacting preferentially with the IκB kinase β subunit
Ogino, S
Tsuruma, K
Uehara, T
Nomura, Y
MOLECULAR PHARMACOLOGY, 2004, 65 (06) : 1344 - 1351
[8] Parkin mediates neuroprotection through activation of IκB kinase/nuclear factor-κB signaling
Henn, Iris H.
Bouman, Lena
Schlehe, Julia S.
Schlierf, Anita
Schramm, Julia E.
Wegener, Elmar
Nakaso, Kazuhiro
Culmsee, Carsten
Berninger, Benedikt
Krappmann, Daniel
Tatzelt, Joerg
Winklhofer, Konstanze F.
JOURNAL OF NEUROSCIENCE, 2007, 27 (08): : 1868 - 1878
[9] Regulation of IκB kinase ε expression by the androgen receptor and the nuclear factor-κB transcription factor in prostate cancer
Peant, Benjamin
Diallo, Jean-Simon
Lessard, Laurent
Delvoye, Nathalie
Le Page, Cecile
Saad, Fred
Mes-Masson, Anne-Marie
MOLECULAR CANCER RESEARCH, 2007, 5 (01) : 87 - 94
[10] IκB-ζ:: An inducible regulator of nuclear factor-κB
Muta, Tatsushi
INTERLEUKINS, 2006, 74 : 301 - 316

← 1 2 3 4 5 →